Novartis
This role involves developing innovative biochemical and biophysical assays to characterize protein targets and investigate compound mechanisms of action for oncology drug discovery projects. The position requires hands-on laboratory experience with techniques such as surface plasmon resonance and fluorescence-based assays to support both low molecular weight and radioligand therapy programs. The successful candidate will collaborate with multidisciplinary teams to generate high-quality scientific insights and present findings to internal stakeholders.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
Senior Scientist in Centre for Structure & Interactions
Novo Nordisk A/S
Associate Scientist
Novo Nordisk A/S
Postdoctoral Research Fellow – Quantitative Biosciences Early Discovery
Merck & Co., Inc.
Senior Scientist, Biophysics
Treeline Biosciences
Scientist I
University of Wisconsin–Madison
Scientist, Pharmacokinetics
MSD